Haptocorrin as marker of disease progression in fibrolamellar hepatocellular carcinoma.

Abstract

AIMS No valid markers are routinely available to follow disease progression in patients with fibrolamellar hepatocellular carcinoma (FLHCC). We report data suggesting that the vitamin B12 binding protein haptocorrin (HC) may prove a suitable marker. METHODS We monitored a 15-year-old boy diagnosed to have FLHCC by measuring the common markers alanine… (More)
DOI: 10.1016/j.ejso.2010.11.001

Topics

  • Presentations referencing similar topics